Literature DB >> 10593564

Diabetes prone BB rats are severely deficient in natural killer T cells.

N N Iwakoshi1, D L Greiner, A A Rossini, J P Mordes.   

Abstract

Diabetes prone (DP) BB rats develop spontaneous autoimmune hyperglycemia. Coisogenic diabetes resistant (DR) BB rats develop diabetes in response to immunological and environmental perturbants, but not spontaneously. Both are used to model human insulin-dependent diabetes mellitus (IDDM). Deficiencies in natural killer (NK) T cells have been implicated in the expression of human IDDM, but little is known of their phenotype or function in the rat. We now report that the phenotype of NK T cells in the rat is alphabetaTcR+ CD8+ CD4-, comparable to the NK T cell phenotype reported for humans, which is alphabetaTcR+ CD4- Valpha24-JalphaQ, and either CD8- or CD8alphaalpha+. We also report that DP- but not DR-BB rats are severely deficient in splenic and intrahepatic NKR-P1+ alphabetaTcR+ (NK T) cells. Because RT6+ T cells are deficient in DP-BB rats, and because depletion of cells expressing RT6 induces IDDM in DR-BB rats, we studied NK T cells for expression of this antigen. We observed that the majority of rat NK T cells express RT6+. In addition, injection of cytotoxic anti-RT6.1 monoclonal antibody depleted splenic and intrahepatic RT6+ NK T cells, T cells, and NK cells, but left intact the RT6- subset of each population. These results suggest that deficiencies in NK T cells may play a role in the susceptibility of DP- and DR-BB rats, respectively, to spontaneous and induced autoimmune IDDM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593564     DOI: 10.3109/08916939908993854

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  7 in total

Review 1.  The cells that knew too much.

Authors:  A G Baxter
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha.

Authors:  D Baeten; N Van Damme; F Van den Bosch; E Kruithof; M De Vos; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

3.  Loss of T cell and B cell quiescence precedes the onset of microbial flora-dependent wasting disease and intestinal inflammation in Gimap5-deficient mice.

Authors:  Michael J Barnes; Halil Aksoylar; Philippe Krebs; Tristan Bourdeau; Carrie N Arnold; Yu Xia; Kevin Khovananth; Isaac Engel; Sosathya Sovath; Kristin Lampe; Eleana Laws; Amy Saunders; Geoffrey W Butcher; Mitchell Kronenberg; Kris Steinbrecher; David Hildeman; H Leighton Grimes; Bruce Beutler; Kasper Hoebe
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

4.  Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.

Authors:  Y N Naumov; K S Bahjat; R Gausling; R Abraham; M A Exley; Y Koezuka; S B Balk; J L Strominger; M Clare-Salzer; S B Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

5.  A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes.

Authors:  Wafaa M Bassuny; Kenji Ihara; Yuka Sasaki; Ryuichi Kuromaru; Hitoshi Kohno; Nobuo Matsuura; Toshiro Hara
Journal:  Immunogenetics       Date:  2003-05-16       Impact factor: 2.846

6.  Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model.

Authors:  Luiz F W Roesch; Graciela L Lorca; George Casella; Adriana Giongo; Andres Naranjo; Arianna M Pionzio; Nan Li; Volker Mai; Clive H Wasserfall; Desmond Schatz; Mark A Atkinson; Josef Neu; Eric W Triplett
Journal:  ISME J       Date:  2009-02-19       Impact factor: 10.302

7.  Failure of alpha-galactosylceramide to prevent diabetes in virus-inducible models of type 1 diabetes in the rat.

Authors:  Prerna Chopra; Philip Diiorio; Steven C Pino; S Brian Wilson; Nancy E Phillips; John P Mordes; Aldo A Rossini; Dale L Greiner; Leonard D Shultz; Rita Bortell
Journal:  In Vivo       Date:  2009 Mar-Apr       Impact factor: 2.155

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.